---
title: "Lenabasum reduces CLP-induced sepsis-associated acute lung injury by modulating redox and inflamma"
id: "pubmed-43040058"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-43040058"
content_type: "clinical_feed_article"
specialty: "Critical Care"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/43040058/"
doi: "10.1007/s00210-026-06101-2"
published_at: "2026-11-17T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Lenabasum reduces CLP-induced sepsis-associated acute lung injury by modulating redox and inflamma
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-43040058
- **Specialty:** [Critical Care](https://medichelpline.com/clinical-feed/critical-care.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/43040058/)
- **DOI:** [10.1007/s00210-026-06101-2](https://doi.org/10.1007%2Fs00210-026-06101-2)
- **Published At:** 2026-11-17T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- The investigators used a cecal ligation and puncture (**CLP**) polymicrobial sepsis model to study acute lung injury at 24 hours. 30 male Wistar rats were randomized across five groups: Sham, CLP, CLP + **lenabasum** 1 mg/kg, CLP + **lenabasum** 5 mg/kg, and CLP + dexamethasone 1 mg/kg. - Interventions were given intraperitoneally after induction of sepsis; assessments occurred at the 24-h acute phase. - Primary tissue redox indices measured in lung were reactive oxygen species (**ROS**), malondialdehyde (**MDA**) and reduced glutathione (**GSH**). - The serum inflammation–resolution profile included tumor necrosis factor-alpha (TNF-α), interleukin-8 (IL-8), C-reactive protein (CRP) and lipoxin A4 (**LXA4**). - Histopathological lung damage was evaluated by blinded hematoxylin-eosin staining and a lung injury score (LIS). - CLP increased lung **ROS** and **MDA**, decreased **GSH**, raised serum TNF-α, IL-8, CRP and **LXA4**, and produced clear histopathological lung injury. - Both lenabasum doses lowered **MDA**, reduced serum inflammatory markers and decreased LIS; **LXA4** shifted toward Sham levels with treatment. - At 5 mg/kg, lenabasum additionally reduced **ROS**, increased **GSH**, and attenuated histopathological lung injury more visibly than the lower dose. - The authors reported that lenabasum, particularly at 5 mg/kg, attenuated biochemical disturbances and histopathological lung injury at 24 h after CLP. - The study did not report receptor-dependence experiments; the authors noted that the receptor dependence of effects remains to be established and recommended further preclinical work.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/43040058/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43040058%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/43040058/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/43040058/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/43040058/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/43040058/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/43040058/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/43040058/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43040058%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43040058%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/43040058/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43040058/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43040058/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/43040058/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43040058/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/43040058/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/43040058/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/43040058/#conflict-of-interest) * [ References ](https://pubmed.ncbi.nlm.nih.gov/43040058/#references) * [ Grants and funding ](https://pubmed.ncbi.nlm.nih.gov/43040058/#grants) Title & authors Abstract Conflict of interest statement References Grants and funding Naunyn Schmiedebergs Arch Pharmacol Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Naunyn+Schmiedebergs+Arch+Pharmacol%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Naunyn+Schmiedebergs+Arch+Pharmacol%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43040058/) . 2026 Nov 17. doi: 10.1007/s00210-026-06101-2. Online ahead of print. # Lenabasum attenuates CLP-induced sepsis-associated acute lung injury with coordinated modulation of redox balance and inflammation-resolution profile [Golnaz Ahmadi](https://pubmed.ncbi.nlm.nih.gov/?term=Ahmadi+G&cauthor_id=43040058)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#full-view-affiliation-1 "Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#full-view-affiliation-2 "Toxicology and Poisoning Research Centre, Tehran University of Medical Sciences, Tehran, Iran."), [Mojtaba Mojtahedzadeh](https://pubmed.ncbi.nlm.nih.gov/?term=Mojtahedzadeh+M&cauthor_id=43040058)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#full-view-affiliation-3 "Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."), [Mohammad Sharifzadeh](https://pubmed.ncbi.nlm.nih.gov/?term=Sharifzadeh+M&cauthor_id=43040058)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#full-view-affiliation-1 "Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#full-view-affiliation-2 "Toxicology and Poisoning Research Centre, Tehran University of Medical Sciences, Tehran, Iran."), [Mohammad Hossein Ghahremani](https://pubmed.ncbi.nlm.nih.gov/?term=Ghahremani+MH&cauthor_id=43040058)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#full-view-affiliation-1 "Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#full-view-affiliation-2 "Toxicology and Poisoning Research Centre, Tehran University of Medical Sciences, Tehran, Iran."), [Mahdi Gholami](https://pubmed.ncbi.nlm.nih.gov/?term=Gholami+M&cauthor_id=43040058)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#full-view-affiliation-1 "Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."), [Omid Sabzevari](https://pubmed.ncbi.nlm.nih.gov/?term=Sabzevari+O&cauthor_id=43040058)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#full-view-affiliation-4 "Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. omid@tums.ac.ir.")[ 5 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#full-view-affiliation-5 "Toxicology and Poisoning Research Centre, Tehran University of Medical Sciences, Tehran, Iran. omid@tums.ac.ir.")[ 6 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#full-view-affiliation-6 "Iranian Association of Pharmaceutical Scientists, Tehran, Iran. omid@tums.ac.ir.")[ 7 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#full-view-affiliation-7 "Iranian Society of Toxicology, Tehran, Iran. omid@tums.ac.ir.") Affiliations Expand ### Affiliations * 1 Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. * 2 Toxicology and Poisoning Research Centre, Tehran University of Medical Sciences, Tehran, Iran. * 3 Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. * 4 Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. omid@tums.ac.ir. * 5 Toxicology and Poisoning Research Centre, Tehran University of Medical Sciences, Tehran, Iran. omid@tums.ac.ir. * 6 Iranian Association of Pharmaceutical Scientists, Tehran, Iran. omid@tums.ac.ir. * 7 Iranian Society of Toxicology, Tehran, Iran. omid@tums.ac.ir. * PMID: **43040058** * DOI: [ 10.1007/s00210-026-06101-2 ](https://doi.org/10.1007/s00210-026-06101-2) Item in Clipboard # Lenabasum attenuates CLP-induced sepsis-associated acute lung injury with coordinated modulation of redox balance and inflammation-resolution profile Golnaz Ahmadi et al. Naunyn Schmiedebergs Arch Pharmacol. 2026. Show details Display options Display options Format Abstract PubMed PMID Naunyn Schmiedebergs Arch Pharmacol Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Naunyn+Schmiedebergs+Arch+Pharmacol%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Naunyn+Schmiedebergs+Arch+Pharmacol%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43040058/) . 2026 Nov 17. doi: 10.1007/s00210-026-06101-2. Online ahead of print. ### Authors [Golnaz Ahmadi](https://pubmed.ncbi.nlm.nih.gov/?term=Ahmadi+G&cauthor_id=43040058)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#short-view-affiliation-1 "Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#short-view-affiliation-2 "Toxicology and Poisoning Research Centre, Tehran University of Medical Sciences, Tehran, Iran."), [Mojtaba Mojtahedzadeh](https://pubmed.ncbi.nlm.nih.gov/?term=Mojtahedzadeh+M&cauthor_id=43040058)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#short-view-affiliation-3 "Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."), [Mohammad Sharifzadeh](https://pubmed.ncbi.nlm.nih.gov/?term=Sharifzadeh+M&cauthor_id=43040058)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#short-view-affiliation-1 "Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#short-view-affiliation-2 "Toxicology and Poisoning Research Centre, Tehran University of Medical Sciences, Tehran, Iran."), [Mohammad Hossein Ghahremani](https://pubmed.ncbi.nlm.nih.gov/?term=Ghahremani+MH&cauthor_id=43040058)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#short-view-affiliation-1 "Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#short-view-affiliation-2 "Toxicology and Poisoning Research Centre, Tehran University of Medical Sciences, Tehran, Iran."), [Mahdi Gholami](https://pubmed.ncbi.nlm.nih.gov/?term=Gholami+M&cauthor_id=43040058)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#short-view-affiliation-1 "Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."), [Omid Sabzevari](https://pubmed.ncbi.nlm.nih.gov/?term=Sabzevari+O&cauthor_id=43040058)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#short-view-affiliation-4 "Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. omid@tums.ac.ir.")[ 5 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#short-view-affiliation-5 "Toxicology and Poisoning Research Centre, Tehran University of Medical Sciences, Tehran, Iran. omid@tums.ac.ir.")[ 6 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#short-view-affiliation-6 "Iranian Association of Pharmaceutical Scientists, Tehran, Iran. omid@tums.ac.ir.")[ 7 ](https://pubmed.ncbi.nlm.nih.gov/43040058/#short-view-affiliation-7 "Iranian Society of Toxicology, Tehran, Iran. omid@tums.ac.ir.") ### Affiliations * 1 Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. * 2 Toxicology and Poisoning Research Centre, Tehran University of Medical Sciences, Tehran, Iran. * 3 Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. * 4 Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. omid@tums.ac.ir. * 5 Toxicology and Poisoning Research Centre, Tehran University of Medical Sciences, Tehran, Iran. omid@tums.ac.ir. * 6 Iranian Association of Pharmaceutical Scientists, Tehran, Iran. omid@tums.ac.ir. * 7 Iranian Society of Toxicology, Tehran, Iran. omid@tums.ac.ir. * PMID: **43040058** * DOI: [ 10.1007/s00210-026-06101-2 ](https://doi.org/10.1007/s00210-026-06101-2) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract Sepsis-associated acute lung injury is a major experimental counterpart of human acute respiratory distress syndrome and involves inflammatory activation, redox imbalance, and structural lung damage. Lenabasum (JBT-101), a selective cannabinoid receptor type 2 (CB2) agonist, has shown anti-inflammatory and immunomodulatory properties in non-septic inflammation, but its effects in acute polymicrobial sepsis-associated lung injury remain poorly defined. This study evaluated lenabasum in a cecal ligation and puncture (CLP)-induced polymicrobial sepsis model during the acute 24-h phase, focusing on lung oxidative/antioxidant indices, the serum inflammation-resolution profile, and histopathological changes. 30 male Wistar rats were allocated to Sham, CLP, CLP + lenabasum 1 mg/kg, CLP + lenabasum 5 mg/kg, or CLP + dexamethasone 1 mg/kg groups. Interventions were administered intraperitoneally after sepsis induction. At 24 h, lung reactive oxygen species (ROS), malondialdehyde (MDA), and reduced glutathione (GSH) were measured. Serum tumor necrosis factor-alpha (TNF-α), interleukin-8 (IL-8), C-reactive protein (CRP), and lipoxin A4 (LXA4) were assessed as the inflammation-resolution profile. Lung injury was evaluated under blinded conditions using hematoxylin-eosin (H&E) staining and lung injury score (LIS). CLP increased lung ROS and MDA, decreased GSH, elevated serum TNF-α, IL-8, CRP, and LXA4, and induced histopathological lung injury. Both lenabasum doses reduced MDA, serum inflammatory markers, and LIS and shifted LXA4 toward Sham levels. At 5 mg/kg, lenabasum also reduced ROS, increased GSH, and attenuated histopathological lung injury. Lenabasum, particularly at 5 mg/kg, attenuated biochemical disturbances and histopathological lung injury at 24 h after CLP. These findings support further preclinical investigation of lenabasum, while the receptor dependence of its effects remains to be established. **Keywords:** Cecal ligation and puncture (CLP); Inflammation–resolution profile; Lenabasum (JBT-101); Oxidative stress; Sepsis; Sepsis-associated acute lung injury. © 2026. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement Declarations. Clinical trial number: Not applicable. Competing interests: The authors declare no competing interests. ## References 1. 1. American Veterinary Medical Association (2020) AVMA Guidelines for the Euthanasia of Animals: 2020 Edition. American Veterinary Medical Association, Schaumburg 2. 1. Bancroft JD, Gamble M (eds) (2008) Theory and practice of histological techniques, 6th ed. Churchill Livingstone Elsevier, Edinburgh 3. 1. Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A et al (2016) Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315:788. - [DOI](https://doi.org/10.1001/jama.2016.0291) - [PubMed](https://pubmed.ncbi.nlm.nih.gov/26903337/) 4. 1. Burstein S (2021) Molecular mechanisms for the inflammation-resolving actions of Lenabasum. Mol Pharmacol 99:125–132. - [DOI](https://doi.org/10.1124/molpharm.120.000083) - [PubMed](https://pubmed.ncbi.nlm.nih.gov/33239333/) 5. 1. Çakır M, Tekin S, Okan A, Çakan P, Doğanyiğit Z (2020) The ameliorating effect of cannabinoid type 2 receptor activation on brain, lung, liver and heart damage in cecal ligation and puncture-induced sepsis model in rats. Int Immunopharmacol 78:105978. - [DOI](https://doi.org/10.1016/j.intimp.2019.105978) - [PubMed](https://pubmed.ncbi.nlm.nih.gov/31767546/) Show all 55 references ## Grants and funding * [ 68241/Vice Chancellor for Research, Tehran University of Medical Sciences ](https://pubmed.ncbi.nlm.nih.gov/?term=68241%2FVice+Chancellor+for+Research%2C+Tehran+University+of+Medical+Sciences%5BGrants+and+Funding%5D&sort=date&sort_order=desc "All articles for grant 68241/Vice Chancellor for Research, Tehran University of Medical Sciences") [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM **Send To** * [Clipboard](https://pubmed.ncbi.nlm.nih.gov/43040058/) * [Email](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43040058%2F%23open-email-panel) * [Save](https://pubmed.ncbi.nlm.nih.gov/43040058/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43040058%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43040058%2F%23open-collections-panel) * [Citation Manager](https://pubmed.ncbi.nlm.nih.gov/43040058/) [x] NCBI Literature Resources [MeSH](https://www.ncbi.nlm.nih.gov/mesh/) [PMC](https://www.ncbi.nlm.nih.gov/pmc/) [Bookshelf](https://www.ncbi.nlm.nih.gov/books) [Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthoriz
## Related Clinical Research

- [LIF-Engineered Mesenchymal Stromal Cells Reduce Mortality and Reprogram Cytokines in LPS Endotoxem](https://medichelpline.com/clinical-feed/pubmed-42969209.md) (DOI: 10.1111/1348-0421.70102)
- [Corticosteroid Therapy in Pneumonia and Critical Illness: Agent Selection, Dosing, Monitoring, Int](https://medichelpline.com/clinical-feed/pubmed-42638128.md) (DOI: 10.1186/s41479-026-00209-y)
- [Aggressive NK‑cell Leukemia with HLH and Organ Failure Bridged to Allogeneic HSCT — Case Report](https://medichelpline.com/clinical-feed/frontiers-in-immunology-15-case-report-fulminant-aggressive-nk-cell-leukemia-with-hemophagocytic.md)
- [Piecing Together the Adrenal Puzzle: CAI Score and Postoperative Testing](https://medichelpline.com/clinical-feed/endocrine-news-1-piecing-together-the-adrenal-puzzle.md)
- [Surgical-name Embeddings Using Large Language Models for Confounding Adjustment in Perioperative O](https://medichelpline.com/clinical-feed/medrxiv-14-large-language-model-embeddings-of-surgical-procedural-names-for-confounding.md)

## Navigation
- [← Back to Critical Care Feed](https://medichelpline.com/clinical-feed/critical-care.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.